questionsmedicales.fr
Cellules
Neurones
Neurofibres
Neurofibres cholinergiques
Neurofibres parasympathiques postganglionnaires
Neurofibres parasympathiques postganglionnaires : Questions médicales fréquentes
Termes MeSH sélectionnés :
Randomized Controlled Trials as Topic
Diagnostic
5
Dysfonction parasympathique
Tests neurologiques
Électromyographie
Imagerie par résonance magnétique
Sécheresse buccale
Troubles de la digestion
Tests sanguins
Inflammation
Fonction parasympathique
Réponse pupillaire
Symptômes
5
Sécheresse buccale
Constipation
Dysautonomie
Palpitations
Troubles de la sudation
Dysfonction parasympathique
Atteinte nerveuse
Engourdissements
Troubles de la miction
Dysfonction parasympathique
Prévention
5
Prévention
Gestion du stress
Exercice régulier
Système nerveux
Alimentation saine
Santé nerveuse
Contrôle du stress
Symptômes
Bilans de santé
Détection précoce
Traitements
5
Médicaments
Thérapie physique
Médicaments anticholinergiques
Dysfonction
Thérapie comportementale
Qualité de vie
Interventions chirurgicales
Dysfonction
Changements de mode de vie
Alimentation équilibrée
Complications
5
Complications
Troubles digestifs
Troubles de la vision
Atteinte nerveuse
Problèmes de miction
Traitement
Infections urinaires
Dysfonction
Circulation sanguine
Dysfonction nerveuse
Facteurs de risque
5
Stress chronique
Système nerveux
Maladies auto-immunes
Neurofibres
Hérédité
Troubles nerveux
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Neurofibres parasympathiques postganglionnaires : Questions médicales les plus fréquentes",
"headline": "Neurofibres parasympathiques postganglionnaires : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Neurofibres parasympathiques postganglionnaires : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-08",
"dateModified": "2025-03-03",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Neurofibres parasympathiques postganglionnaires"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Neurofibres cholinergiques",
"url": "https://questionsmedicales.fr/mesh/D002799",
"about": {
"@type": "MedicalCondition",
"name": "Neurofibres cholinergiques",
"code": {
"@type": "MedicalCode",
"code": "D002799",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.671.501.234"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Neurofibres parasympathiques postganglionnaires",
"alternateName": "Parasympathetic Fibers, Postganglionic",
"code": {
"@type": "MedicalCode",
"code": "D017777",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Rachel M Fenning",
"url": "https://questionsmedicales.fr/author/Rachel%20M%20Fenning",
"affiliation": {
"@type": "Organization",
"name": "Department of Child and Adolescent Studies, Center for Autism, California State University, Fullerton, California, USA."
}
},
{
"@type": "Person",
"name": "Stephen A Erath",
"url": "https://questionsmedicales.fr/author/Stephen%20A%20Erath",
"affiliation": {
"@type": "Organization",
"name": "College of Human Sciences, Auburn University, Auburn, Alabama, USA."
}
},
{
"@type": "Person",
"name": "Jason K Baker",
"url": "https://questionsmedicales.fr/author/Jason%20K%20Baker",
"affiliation": {
"@type": "Organization",
"name": "Department of Child and Adolescent Studies, Center for Autism, California State University, Fullerton, California, USA."
}
},
{
"@type": "Person",
"name": "Frances Rucker",
"url": "https://questionsmedicales.fr/author/Frances%20Rucker",
"affiliation": {
"@type": "Organization",
"name": "New England College of Optometry, 424 Beacon St, Boston, MA, 02115, USA. Electronic address: ruckerf@neco.edu."
}
},
{
"@type": "Person",
"name": "Chris Taylor",
"url": "https://questionsmedicales.fr/author/Chris%20Taylor",
"affiliation": {
"@type": "Organization",
"name": "New England College of Optometry, 424 Beacon St, Boston, MA, 02115, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Topical diquafosol versus hyaluronic acid for the treatment of dry eye disease: a meta-analysis of randomized controlled trials.",
"datePublished": "2023-05-10",
"url": "https://questionsmedicales.fr/article/37162564",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00417-023-06083-4"
}
},
{
"@type": "ScholarlyArticle",
"name": "The UPDATE trial (UVB Phototherapy in Dermatology for ATopic Eczema): study protocol for a randomized controlled trial of narrowband UVB with optimal topical therapy versus optimal topical therapy in patients with atopic eczema.",
"datePublished": "2024-07-16",
"url": "https://questionsmedicales.fr/article/39014498",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s13063-024-08334-z"
}
},
{
"@type": "ScholarlyArticle",
"name": "Design and Methodological Issues of Within-Person (Split-Body) Randomized Controlled Trials Evaluating a Topical Treatment: A Systematic Review.",
"datePublished": "2023-03-29",
"url": "https://questionsmedicales.fr/article/36990057",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1159/000530149"
}
},
{
"@type": "ScholarlyArticle",
"name": "Laser and light therapy combined with topical minoxidil for alopecia areata: a systematic review and meta-analysis of randomized controlled trials.",
"datePublished": "2023-02-17",
"url": "https://questionsmedicales.fr/article/36800063",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10103-023-03734-0"
}
},
{
"@type": "ScholarlyArticle",
"name": "Nd:YAG/Er:YAG dual laser vs. topical steroid to treat vulvar lichen sclerosus: study protocol of a randomized controlled trial.",
"datePublished": "2023-05-05",
"url": "https://questionsmedicales.fr/article/37145134",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00404-023-07055-z"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Cellules",
"item": "https://questionsmedicales.fr/mesh/D002477"
},
{
"@type": "ListItem",
"position": 3,
"name": "Neurones",
"item": "https://questionsmedicales.fr/mesh/D009474"
},
{
"@type": "ListItem",
"position": 4,
"name": "Neurofibres",
"item": "https://questionsmedicales.fr/mesh/D009412"
},
{
"@type": "ListItem",
"position": 5,
"name": "Neurofibres cholinergiques",
"item": "https://questionsmedicales.fr/mesh/D002799"
},
{
"@type": "ListItem",
"position": 6,
"name": "Neurofibres parasympathiques postganglionnaires",
"item": "https://questionsmedicales.fr/mesh/D017777"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Neurofibres parasympathiques postganglionnaires - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Neurofibres parasympathiques postganglionnaires",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-09",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Neurofibres parasympathiques postganglionnaires",
"description": "Comment diagnostiquer une dysfonction parasympathique ?\nQuels examens sont utilisés pour évaluer les neurofibres ?\nQuels symptômes nécessitent un diagnostic ?\nLes tests sanguins sont-ils utiles pour le diagnostic ?\nComment évaluer la fonction parasympathique ?",
"url": "https://questionsmedicales.fr/mesh/D017777?mesh_terms=Randomized+Controlled+Trials+as+Topic#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Neurofibres parasympathiques postganglionnaires",
"description": "Quels sont les symptômes d'une atteinte parasympathique ?\nComment se manifeste une dysautonomie ?\nLes troubles de la sudation sont-ils liés ?\nQuels signes indiquent une atteinte nerveuse ?\nLes troubles de la miction sont-ils fréquents ?",
"url": "https://questionsmedicales.fr/mesh/D017777?mesh_terms=Randomized+Controlled+Trials+as+Topic#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Neurofibres parasympathiques postganglionnaires",
"description": "Peut-on prévenir les troubles parasympathiques ?\nL'exercice régulier aide-t-il à prévenir ?\nUne alimentation saine est-elle bénéfique ?\nLe contrôle du stress est-il important ?\nLes bilans de santé réguliers sont-ils recommandés ?",
"url": "https://questionsmedicales.fr/mesh/D017777?mesh_terms=Randomized+Controlled+Trials+as+Topic#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Neurofibres parasympathiques postganglionnaires",
"description": "Quels traitements sont disponibles pour la dysfonction ?\nLes médicaments anticholinergiques sont-ils utilisés ?\nLa thérapie comportementale est-elle efficace ?\nDes interventions chirurgicales sont-elles possibles ?\nComment les changements de mode de vie aident-ils ?",
"url": "https://questionsmedicales.fr/mesh/D017777?mesh_terms=Randomized+Controlled+Trials+as+Topic#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Neurofibres parasympathiques postganglionnaires",
"description": "Quelles complications peuvent survenir ?\nLes troubles de la vision sont-ils une complication ?\nDes problèmes de miction peuvent-ils s'aggraver ?\nLes infections urinaires sont-elles fréquentes ?\nLes troubles de la circulation sanguine sont-ils possibles ?",
"url": "https://questionsmedicales.fr/mesh/D017777?mesh_terms=Randomized+Controlled+Trials+as+Topic#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Neurofibres parasympathiques postganglionnaires",
"description": "Quels facteurs augmentent le risque de dysfonction ?\nLe stress chronique est-il un facteur de risque ?\nLes maladies auto-immunes sont-elles un risque ?\nL'obésité influence-t-elle le risque ?\nL'hérédité joue-t-elle un rôle ?",
"url": "https://questionsmedicales.fr/mesh/D017777?mesh_terms=Randomized+Controlled+Trials+as+Topic#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une dysfonction parasympathique ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un diagnostic peut inclure des tests neurologiques et des examens d'imagerie."
}
},
{
"@type": "Question",
"name": "Quels examens sont utilisés pour évaluer les neurofibres ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'électromyographie et l'imagerie par résonance magnétique sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Quels symptômes nécessitent un diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme la sécheresse buccale ou des troubles de la digestion peuvent alerter."
}
},
{
"@type": "Question",
"name": "Les tests sanguins sont-ils utiles pour le diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent aider à évaluer des marqueurs d'inflammation ou d'autres anomalies."
}
},
{
"@type": "Question",
"name": "Comment évaluer la fonction parasympathique ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de réponse pupillaire et de fréquence cardiaque peuvent être effectués."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une atteinte parasympathique ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent la sécheresse buccale, la constipation et des troubles de la vision."
}
},
{
"@type": "Question",
"name": "Comment se manifeste une dysautonomie ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut se manifester par des vertiges, des palpitations et des troubles digestifs."
}
},
{
"@type": "Question",
"name": "Les troubles de la sudation sont-ils liés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une dysfonction parasympathique peut entraîner des anomalies de la sudation."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une atteinte nerveuse ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme des engourdissements ou des douleurs peuvent indiquer une atteinte."
}
},
{
"@type": "Question",
"name": "Les troubles de la miction sont-ils fréquents ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des problèmes de miction peuvent survenir en raison d'une dysfonction parasympathique."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les troubles parasympathiques ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines mesures préventives incluent un mode de vie sain et la gestion du stress."
}
},
{
"@type": "Question",
"name": "L'exercice régulier aide-t-il à prévenir ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier peut renforcer le système nerveux et prévenir des troubles."
}
},
{
"@type": "Question",
"name": "Une alimentation saine est-elle bénéfique ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en nutriments peut soutenir la santé nerveuse."
}
},
{
"@type": "Question",
"name": "Le contrôle du stress est-il important ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut aggraver les symptômes, donc le contrôle est essentiel."
}
},
{
"@type": "Question",
"name": "Les bilans de santé réguliers sont-ils recommandés ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des bilans réguliers peuvent aider à détecter précocement des problèmes."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour la dysfonction ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des médicaments, la thérapie physique et des changements de mode de vie."
}
},
{
"@type": "Question",
"name": "Les médicaments anticholinergiques sont-ils utilisés ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent être prescrits pour traiter certains symptômes de dysfonction."
}
},
{
"@type": "Question",
"name": "La thérapie comportementale est-elle efficace ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut aider à gérer les symptômes et améliorer la qualité de vie."
}
},
{
"@type": "Question",
"name": "Des interventions chirurgicales sont-elles possibles ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Dans certains cas, des interventions chirurgicales peuvent être envisagées."
}
},
{
"@type": "Question",
"name": "Comment les changements de mode de vie aident-ils ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée et l'exercice régulier peuvent améliorer les symptômes."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des troubles digestifs sévères et des problèmes cardiaques."
}
},
{
"@type": "Question",
"name": "Les troubles de la vision sont-ils une complication ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles de la vision peuvent survenir en raison d'une atteinte nerveuse."
}
},
{
"@type": "Question",
"name": "Des problèmes de miction peuvent-ils s'aggraver ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, sans traitement, les problèmes de miction peuvent devenir plus graves."
}
},
{
"@type": "Question",
"name": "Les infections urinaires sont-elles fréquentes ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent survenir en raison de troubles de la miction liés à la dysfonction."
}
},
{
"@type": "Question",
"name": "Les troubles de la circulation sanguine sont-ils possibles ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles de la circulation peuvent survenir en raison d'une dysfonction nerveuse."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de dysfonction ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des facteurs comme le diabète, l'hypertension et l'âge avancé augmentent le risque."
}
},
{
"@type": "Question",
"name": "Le stress chronique est-il un facteur de risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut contribuer à la dysfonction du système nerveux."
}
},
{
"@type": "Question",
"name": "Les maladies auto-immunes sont-elles un risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines maladies auto-immunes peuvent affecter les neurofibres parasympathiques."
}
},
{
"@type": "Question",
"name": "L'obésité influence-t-elle le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'obésité peut augmenter le risque de troubles nerveux et de dysfonction."
}
},
{
"@type": "Question",
"name": "L'hérédité joue-t-elle un rôle ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de troubles nerveux peuvent augmenter le risque."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 03/03/2025
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
Department of Child and Adolescent Studies, Center for Autism, California State University, Fullerton, California, USA.
Department of Psychological Science and The Claremont Autism Center, Claremont McKenna College, Claremont, California, USA.
Publications dans "Neurofibres parasympathiques postganglionnaires" :
3 publications dans cette catégorie
Affiliations :
College of Human Sciences, Auburn University, Auburn, Alabama, USA.
Publications dans "Neurofibres parasympathiques postganglionnaires" :
3 publications dans cette catégorie
Affiliations :
Department of Child and Adolescent Studies, Center for Autism, California State University, Fullerton, California, USA.
Publications dans "Neurofibres parasympathiques postganglionnaires" :
2 publications dans cette catégorie
Affiliations :
New England College of Optometry, 424 Beacon St, Boston, MA, 02115, USA. Electronic address: ruckerf@neco.edu.
Publications dans "Neurofibres parasympathiques postganglionnaires" :
2 publications dans cette catégorie
Affiliations :
New England College of Optometry, 424 Beacon St, Boston, MA, 02115, USA.
Publications dans "Neurofibres parasympathiques postganglionnaires" :
2 publications dans cette catégorie
Affiliations :
Center for Anatomy and Cell Biology, Institute of Anatomy and Cell Biology - Salzburg Paracelsus Medical University, Salzburg, Austria.
Publications dans "Neurofibres parasympathiques postganglionnaires" :
2 publications dans cette catégorie
Affiliations :
Center for Anatomy and Cell Biology, Institute of Anatomy and Cell Biology - Salzburg Paracelsus Medical University, Salzburg, Austria.
Publications dans "Neurofibres parasympathiques postganglionnaires" :
2 publications dans cette catégorie
Affiliations :
Department of Physiology, Emory University School of Medicine, Atlanta, GA, USA.
Publications dans "Neurofibres parasympathiques postganglionnaires" :
2 publications dans cette catégorie
Affiliations :
Department of Physiology, Emory University School of Medicine, Atlanta, GA, USA.
Publications dans "Neurofibres parasympathiques postganglionnaires" :
2 publications dans cette catégorie
Affiliations :
Department of Physiology, Emory University School of Medicine, Atlanta, GA, USA.
Publications dans "Neurofibres parasympathiques postganglionnaires" :
2 publications dans cette catégorie
Affiliations :
Department of Physiology, Emory University School of Medicine, Atlanta, GA, USA.
Publications dans "Neurofibres parasympathiques postganglionnaires" :
2 publications dans cette catégorie
Affiliations :
Department of Psychological Science, University of California, Irvine, Irvine, CA, United States.
Publications dans "Neurofibres parasympathiques postganglionnaires" :
2 publications dans cette catégorie
Affiliations :
ULR 2694- METRICS: Evaluation des technologies de santé et des pratiques médicales, University of Lille, 59000, Lille, France.
CHU Lille, Department of Neonatology, Jeanne de Flandre Hospital, 59000, Lille, France.
Publications dans "Neurofibres parasympathiques postganglionnaires" :
2 publications dans cette catégorie
Affiliations :
ULR 2694- METRICS: Evaluation des technologies de santé et des pratiques médicales, University of Lille, 59000, Lille, France.
CHU Lille, CIC-IT 1403, Centre D'Innovation Technologique, 59000, Lille, France.
Publications dans "Neurofibres parasympathiques postganglionnaires" :
2 publications dans cette catégorie
Affiliations :
Faculty of Medicine, Osaka University, Osaka, Japan.
Graduate School of Frontiers Bioscience, Osaka University, Osaka, Japan.
Publications dans "Neurofibres parasympathiques postganglionnaires" :
1 publication dans cette catégorie
Affiliations :
Department of Cell Biology, University of Virginia, Charlottesville, Virginia. Electronic address: kld5u@virginia.edu.
Publications dans "Neurofibres parasympathiques postganglionnaires" :
1 publication dans cette catégorie
Affiliations :
Yaroslavl State Medical University, Ministry of Health of the Russian Federation, Yaroslavl, Russia.
Publications dans "Neurofibres parasympathiques postganglionnaires" :
1 publication dans cette catégorie
Affiliations :
Yaroslavl State Medical University, Ministry of Health of the Russian Federation, Yaroslavl, Russia.
Publications dans "Neurofibres parasympathiques postganglionnaires" :
1 publication dans cette catégorie
Affiliations :
Yaroslavl State Medical University, Ministry of Health of the Russian Federation, Yaroslavl, Russia.
Publications dans "Neurofibres parasympathiques postganglionnaires" :
1 publication dans cette catégorie
Affiliations :
Yaroslavl State Medical University, Ministry of Health of the Russian Federation, Yaroslavl, Russia. mpm@ysmu.ru.
Publications dans "Neurofibres parasympathiques postganglionnaires" :
Diquafosol enhances fluid transfer and mucin secretion on ocular surface, which has been suggested as an effective treatment for dry eye disease (DED). The aim of the systematic review and meta-analys...
Relevant randomized controlled trials were obtained via search of electronic including PubMed, Embase, Cochrane Library, and Web of Science. A random-effects model was used to pool the results after i...
A total of nine RCTs involving 1295 patients with DED were included in the meta-analysis. Compared to treatment with 0.1% HA, topical treatment with 3% diquafosol significantly improved the Ocular Sur...
Topical treatment with 3% diquafosol may be more effective than 0.1% HA for patients with DED. However, the long-term efficacy and tolerability of diquafosol still need to be determined....
Narrowband ultraviolet B (NB-UVB) phototherapy is commonly prescribed for patients with moderate-to-severe atopic eczema (AE). The efficacy of NB-UVB, however, has not yet properly been established, a...
A pragmatic, multicenter, PROBE trial will be performed with 1:1 randomization of 316 adult patients with moderate-to-severe AE who have inadequate disease control with topical therapy and who are eli...
The UPDATE trial aims to provide high-quality evidence regarding the (cost-)effectiveness and safety of NB-UVB phototherapy in moderate-to-severe AE patients. Challenges that are addressed in the prot...
ClinicalTrials.gov NCT05704205. Registered on December 8, 2022....
Topical drugs are often used as first-line treatment for dermatological conditions. A within-person design may then be well adapted: it consists of randomizing lesions/body sites rather than patients,...
The aim of this review was to provide a methodological overview of within-person randomized trials (WP-RCTs) in dermatology....
We searched for eligible trials published between 2017 and 2021 in MEDLINE, Embase, and Central in dermatology journals and the 6 highest-impact-factor general medical journals. Two authors selected p...
From 1,034 articles identified, we included 54 WP-RCTs, mainly for acne vulgaris, psoriasis, actinic keratosis, and atopic dermatitis. In most of the trials, patients had only 2 lesions/body sites. In...
Our systematic review highlights that despite the publication of the CONSORT checklist extension for WP-RCTs in 2017, this design is rarely used, and when it is, there are methodological and reporting...
We aim to evaluate the clinical efficacy and safety of using laser and light combined with topical minoxidil for alopecia areata. We searched PubMed, Embase, Web of Science, the Cochrane Library, Chin...
Vulvar lichen sclerosus (LS) is a chronic debilitating inflammatory skin disease. Today, the gold standard is a life-long topical steroid treatment. Alternative options are highly desired. We present ...
We recruited 66 patients, 44 in the laser arm and 22 in the steroid arm. Patients with a physician-administered clinical LS score ≥ 4 were included. Participants received either four laser treatments ...
The findings of this trial have the potential to offer a novel treatment option for LS. The standardized Nd:YAG/Er:YAG laser settings and the treatment regime are presented in this paper....
NCT03926299....
Alopecia areata (AA) is a common autoimmune skin disease. Our study aimed to systematically evaluate the efficacy and safety of compound glycyrrhizin (CG) combined with topical minoxidil therapy in tr...
We searched the PubMed, EMBASE, Cochrane Library, Web of Science, CNKI, Wanfang, and VIP databases. Randomized controlled trials (RCTs) on CG combined with topical minoxidil therapy compared with topi...
11 RCTs and 1189 patients were included. Compared with topical minoxidil therapy alone, CG combined with topical minoxidil therapy was more effective at improving the clinical efficacy (RR = 1.36, 95%...
The current evidence indicates that CG combined with topical minoxidil therapy is effective and safe for AA. However, owing to the suboptimal quality of the included studies, more high-quality and lar...
The purpose was to identify and summarize the existing evidence on the efficacy and safety of the topical application of olive oil for preventing pressure ulcers (PUs). We included only randomized con...
To investigate the clinical efficacy and safety of topical difamilast in mild-to-moderate atopic dermatitis (AD)....
Only randomized controlled trials (RCTs) that compared topical difamilast with vehicle treatment for patients with AD were included. PubMed, Web of Science, Ovid Medline, Cochrane Library, ClinicalTri...
Five studies enrolling a total of 1009 patients with mild-to-moderate AD were identified. Compared with the topical vehicle, topical difamilast was associated with a significantly higher success rate ...
This meta-analysis suggests that topical difamilast is an effective and safe treatment for mild-to-moderate AD....
Melasma is a chronic relapsing skin condition. Laser therapy is a new advancement in treatment. Whether the topical application of tranexamic acid (TXA) increases the efficacy of laser therapy in mela...
Randomized controlled trials are used to estimate the causal effect of a treatment on a health outcome of interest in a patient population. Often the specified treatment in a randomized controlled tri...
We use causal reasoning to explain why randomized controlled trials of biomarker targets can arrive at conflicting or misleading conclusions. We describe four key threats to the validity of trials of ...
We illustrate these findings using evidence from 15 randomized controlled trials of blood pressure targets for management of hypertension. Randomized trials of blood pressure targets exhibit substanti...
Researchers should critically assess meta-analyses of trials of targets for variation in the types, distributions, and off-target effects of therapies studied. Trial investigators should release detai...